Real-World Evidence: Efficacy Assessments Await FDA Clarity, Pilot Projects

Greater development and use of real-world evidence, such as pragmatic clinical trials and observational studies, to support regulatory decisions on drug efficacy are limited by regulatory, technical and practical hurdles, stakeholders say.